You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 January 2019 - - US-based biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCB) partner Austrianova has successfully encapsulated the live cells used in PharmaCyte's therapy for its planned clinical trial in patients with locally ...
17 January 2019 - Immuno-oncology company Targovax ASA (OSE:TRVX) revealed on Wednesday the receipt of the European patent that will protect its mutant-RAS specific neoantigen peptides, mutant RAS specific T cells and vaccines TG01 and TG02, for the ...
17 January 2019 - Biotechnology company Therachon AG said on Wednesday that it has passed the US Food and Drug Administration's (FDA) orphan drug designation for apraglutide for the treatment of short bowel syndrome (SBS).Short Bowel Syndrome (S...
17 January 2019 - Biotech company Bridge Biotherapeutics Inc revealed on Wednesday the receipt of the US Food and Drug Administration's (FDA) orphan drug designation (ODD) to promote the development of the drug candidate BBT-877 for the treatmen...
17 January 2019 - Diagnostic reagents company Immuno Concepts said on Wednesday that it has passed the Histofluor Rodent LKS Rodent Tissue Slides for manual and Image Navigator use through the US Food and Drug Administration's (FDA) 510(k) proce...
17 January 2019 - Human therapeutics company Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) on Wednesday jointly announced the US Food and Drug Administration (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee's (BRUDAC) recomme...
17 January 2019 - Abbott (NYSE: ABT), a global healthcare company, announced yesterday that it has exercised its option to purchase Cephea Valve Technologies Inc, a privately held medical device company developing a less-invasive heart valve replacem...